Consumer Products
Therapy
Cancer Prevention
Marker Therapeutics
$5.959876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.12 (-1.96%) Today
-$0.04 (-0.67%) After Hours
Why Robinhood?
You can buy or sell MRKR and other stocks, options, ETFs, and crypto commission-free!
About
Marker Therapeutics, Inc. Common Stock, also called Marker Therapeutics, is an immuno-oncology company, which engages in the development of technologies for the treatment of cancer, including metastasis, and infectious diseases. Read More It also involves in developing vaccines for breast, colorectal, ovarian, and non-small cell lung cancer. The company was founded in 1991 and is headquartered in Houston, TX.
Employees
11
Headquarters
Houston, Texas
Founded
1991
Market Cap
277.64M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
309.18K
High Today
$6.08
Low Today
$5.60
Open Price
$6.07
Volume
201.28K
52 Week High
$13.55
52 Week Low
$2.58
Collections
Consumer Products
Therapy
Cancer Prevention
Retail
Health
US
North America
Price Paid on Robinhood
13% Lower
Right Now
52 Week Low
$2.58
Average Price Paid
$6.85
52 Week High
$13.55
Earnings
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
—
Actual
Expected Mar 21, After Hours